-
Ferric Citrate Agent 500 ml bottleCatalog #: BE02-059FFerric Citrate (100x) Agent, 500mlSales unit: each
-
-
Rat MicrogliaCatalog #: R-G-535
Cryopreserved ampule of Rat Microglia containing ≥ 2 million cells
Sales unit: Ampule -
Trypsin Neutralizing Solution, 100 mLCatalog #: CC-5002
Trypsin Neutralizing Solution for use in cell culture, 100 mL
Sales unit: each -
D-HBE-COPD – Diseased Human Bronchial/Tracheal Epithelial Cells – COPDCatalog #: 00195275D-HBE-COPD – Diseased Human Bronchial/Tracheal Epithelial Cells from donors having COPDSales unit: Ampule
-
EGMTM-2 Endothelial Cell Growth Medium-2 BulletKitTM (6 Pack)Catalog #: CC-3162/6
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells (Pack of 6). Available for immediate shipment.
Sales unit: kit -
Rat Cerebellar Granular NeuronsCatalog #: R-CB-503
Cryopreserved ampule of Rat Cerebellar Granular Neurons containing ≥ 4 million cells
Sales unit: each -
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Positive Selection, 10 MillionCatalog #: 2W-400C
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Liter -
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Positive Selection, 20 millionCatalog #: 2W-400B
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥20 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Liter -
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Positive Selection, 40 millionCatalog #: 2W-400A
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥40 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.